ARX Stock Analysis: Buy, Sell, or Hold?
ARX - Accelerant Holdings
$13.68
0.37 (2.78%)
▲
5d:
+4.03%
30d:
+15.54%
90d:
-16.74%
HOLD
MODERATE Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: Mar 19, 2026
0d
Get Alerted When ARX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: ARX is 10.9% above fair value ($12.34). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: ARX is 10.9% above fair value ($12.34). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$27.57
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$17.12
20.1% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 16.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ARX is currently trading at $13.68, which is considered extended relative to its 30-day fair value range of $10.29 to $12.34. The stock's valuation (Forward PE: 15.6) is in line with its historical norms (16.6). Remarkably, the market is currently pricing in an annual earnings decline of 2.1% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, ARX is in a downtrend. The price is approaching resistance at $13.60. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ARX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $17.94 (+34.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ARX is in a downtrend. The price is approaching resistance at $13.60. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ARX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $17.94 (+34.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$10.29 -
$12.34
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.4%
All Signals
- BEARISH: Price significantly overextended (+10.9% above fair value)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 34.8% below Wall St target ($17.94)
Fair Price Analysis
30-Day Fair Range
$10.29 -
$12.34
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$10.91
Resistance Level
$13.60
Current Trend
Downtrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
15.60
Wall Street Target
$17.94
(+34.8%)
Revenue Growth (YoY)
49.2%
Earnings Growth (YoY)
-11.1%
Profit Margin
-166.4%
Valuation Discount vs History
-2.1% cheaper
PE vs Historical
15.6 vs 16.6
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-2.1%
(market-implied from PE analysis)
1-Year Target
$13.03
(-2%)
2-Year Target
$12.76
(-4%)
3-Year Target
$12.49
(-6%)
3-Yr Target (if PE normalizes)
(PE: 16→17)
$13.29
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: 28.3%)
$40.24
(+202%)
Base:
(SPY PE: 15.6, Growth: 28.3%)
$28.09
(+111%)
Bear:
(PE: 13.3, Growth: 28.3%)
$23.88
(+79%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 15.6 to 16.6
Stabilization Target:
$14.16
(+6.4%)
PE Expansion Potential:
+6.4%
Share & Embed Analysis
Last updated: March 31, 2026 10:15 AM ET
Data refreshes hourly during market hours. Next update: 11:15 AM
Data refreshes hourly during market hours. Next update: 11:15 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ARX showing a specific setup today?
Insider Activity (6 Months)
4
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Christopher Lee-Smith
BUY
14700 shares
2025-11-19
Samuel Gaynor
BUY
7500 shares
2025-11-19
Francis James Oneill
BUY
38000 shares
2025-11-18
Top Rated Insurance Brokers Stocks
Top-rated stocks in Insurance Brokers by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
WTW
Willis Towers Watson PLC |
STRONG BUY
18 analysts |
$371 | 58 HOLD |
|
AON
Aon PLC |
HOLD
20 analysts |
$397 | 58 HOLD |
|
AJG
Arthur J Gallagher & Co |
BUY
17 analysts |
$274 | 60 HOLD |
|
MMC
Marsh & McLennan Compani… |
SELL
20 analysts |
$211 | 61 BUY |
|
BWIN
The Baldwin Insurance Gr… |
BUY
8 analysts |
$30 | 57 HOLD |